Medyssey메디쎄이
200580 · KONEX · ₩200580 · 메디쎄이
- Market cap
- ₩44B
- Enterprise value
- —
- P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- ROE
- —
- Net margin
- —
Financial statements not available yet. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−9.2% from the high
₩9,310Today: ₩11,790 – ₩12,000₩13,000
Returns
- 1W−1.7%
- 1M+7.3%
- 3M+12.5%
- 6M−3.6%
- YTD+4.7%
- 1Y+7.4%
- Volume today
- 1,068
- 0.9× the 20-day average
- Traded today
- ₩13M
- Listed shares
- 3,726,079
- EPS (12 months)
- —
🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 44 of 100 (50 is a normal day for this stock).
- MomentumStrong13.7% over the last month; the price is above its 20-day average.
- News impactLow2 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Medyssey stock overview
Medyssey (메디쎄이, KRX: 200580) is listed on KONEX, in the Medical & precision devices sector. The company designs, manufactures and sells orthopedic medical devices, mainly spinal implants and spinal surgical instruments used by orthopedic and neurosurgeons to treat spinal instability, deformities and scoliosis, along with other fixation devices and trauma product lines. Its shares closed at ₩11,800 on Oct 29, 2026, unchanged on the day, giving it a market value of ₩44B.
Key facts
- Market cap
- ₩44B
- Sector
- Medical & precision devices
- Latest price change
- 0.00%
- As of
- Oct 29, 2026
- Main business
- The company designs, manufactures and sells orthopedic medical devices, mainly spinal implants and spinal surgical instruments used by orthopedic and neurosurgeons to treat spinal instability, deformities and scoliosis, along with other fixation devices and trauma product lines.
Quick answers about Medyssey
- What does Medyssey do?
- The company designs, manufactures and sells orthopedic medical devices, mainly spinal implants and spinal surgical instruments used by orthopedic and neurosurgeons to treat spinal instability, deformities and scoliosis, along with other fixation devices and trauma product lines. It sells through distributors and hospitals, exports to 25 countries, and runs subsidiaries in the United States, Mexico and Chile plus a 50% owned joint venture in Chongqing, China.
- What is the market cap of Medyssey?
- The market capitalisation of Medyssey was ₩44B at the close on Oct 29, 2026.
- Who are the largest shareholders of Medyssey?
- According to the latest official filings, the largest reported holders are Dong-A ST (64.47%, as of Mar 27, 2026); Sung Kyung-su (0.10%, as of Oct 21, 2026).
- When is the next earnings report from Medyssey?
- Korean companies rarely announce results dates in advance. Based on when Medyssey filed the same report in past years, its next annual results is expected between Mar 14, 2027 and Mar 16, 2027.
Company profile
The company designs, manufactures and sells orthopedic medical devices, mainly spinal implants and spinal surgical instruments used by orthopedic and neurosurgeons to treat spinal instability, deformities and scoliosis, along with other fixation devices and trauma product lines. It sells through distributors and hospitals, exports to 25 countries, and runs subsidiaries in the United States, Mexico and Chile plus a 50% owned joint venture in Chongqing, China.
Written by AI from the company's latest annual report.
- Korean name
- 메디쎄이
- Themes
- Medical devices
- CEO
- 성경수
- Founded
- Oct 2003
- Listed
- Oct 2015
- Listed shares
- 3,726,079
- Fiscal year ends
- Month 12
- Website
- www.medyssey.co.kr
Similar companies
- TSE131290 · ₩2.9T₩260,500−5.27%
- Kctech281820 · ₩1.9T₩97,500+2.09%
- Classys214150 · ₩1.7T₩26,800−0.74%
- Park Systems140860 · ₩1.6T₩228,500−0.44%
- DI003160 · ₩1.2T₩43,500+0.46%
- Curiox Biosystems445680 · ₩1T₩60,600−2.88%
- LivsMed491000 · ₩1T₩40,450−7.33%
- Seers458870 · ₩907B₩23,650−3.86%
Recent filings
See all- Insider shareholding reportOct 21, 2026
- Other Material Business Matters (Voluntary Disclosure): OdysSI Screw Obtains U.S. FDA 510(k) ClearanceOct 16, 2026
- Insider shareholding reportOct 8, 2026
- Other Material Management Matters (Voluntary Disclosure) (NeckTune™ SA Cervical Cage Obtains U.S. FDA 510(k) Clearance)Oct 1, 2026
- Insider shareholding reportSep 29, 2026
Titles in Korean until English translations are added.
Also known as: Medyssey / 메디쎄이 / 200580 / KRX:200580
Source: KRX statistical information